NCT07199894View on ClinicalTrials.gov

Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE

PHASE3RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

February 1, 2026

Conditions
Nocturnal Enuresis in Children
Interventions
DRUG

Mirabegron (beta3-adrenoceptor agonist), Anticholinergics

Anticholinergic and B3 agonist drugs used for treatment of mono-symptomatic nocturnal enuresis

DRUG

Desmopressin (DDAVP)

ADH analogue in treatment of mono-symptomatic nocturnal enuresis

Trial Locations (1)

Unknown

RECRUITING

Urology and Nephrology center - Mansoura University, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER